Why Life Science Research Is Actually Banned In Fable

In a hypothetical scenario described on Reddit, Anthropic acquires computational biology firm Coefficient Bio for $400 million in April 2026, then two months later deploys silent output-degradation classifiers in Claude targeting biology, chemistry, and drug discovery queries rather than issuing outright refusals. The concern raised is that steering-based suppression without user notification creates a conflict of interest when Anthropic simultaneously runs an internal life sciences group with explicit goals to dominate biological AI workloads. This is speculative or fictional content, not a verified news event.